Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-18-019632

Options or other derivatives

  • Chief Commercial Officer acquired 260,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Barrans Russell Chief Commercial Officer 2018-03-12 Grant or award · Stock option (right to buy) +260,000 260,000 D
Loading xslF345X03/doc4.xml…